Voting rights: Epigenomics AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

Epigenomics AG / Voting rights: Correction Release of a Voting Rights
Notification (§ 21 para. 1
WpHG) released on 11 September 2008 in Accordance with § 26, para. 1
WpHG (German Securities Trading Act) with the Aim of an Europe-wide
Distribution

Publication pursuant to §26 sect.1 WpHG (the German Securities
Trading Act) processed and transmitted by Hugin. The issuer is solely
responsible for the content of this announcement.

----------------------------------------------------------------------
--------------

Issuer:

Epigenomics AG
- ISIN DE000A0BVT96 -
Kleine Präsidentenstr. 1
10178 Berlin
Deutschland

Corrected Voting Rights Notification:

In correction of the voting rights notification dated 10 September
2008 and released by Epigenomics AG on 11 September 2008, Federated
Investors Inc., Pittsburgh, PA, USA on 18 September 2008 made the
following corrected notification in the name and on behalf of
Federated Equity Management Company of Pennsylvania, Pittsburgh, PA,
USA pursuant to § 21 para. 1 WpHG in connection with § 22 para. 1
sent. 1 no. 6 WpHG regarding the holding of voting rights held in
Epigenomics AG:

On 8 September 2008 Federated Equity Management Company of
Pennsylvania exceeded the 20 per cent threshold of § 21 para. 1 WpHG
and held at this date 20.12 per cent of the voting rights (5,375,319
voting rights) in Epigenomics AG.

All 20.12 per cent of the voting rights (5,375,319 voting rights) are
attributed to Federated Equity Management Company of Pennsylvania
pursuant to § 22 para. 1 sent. 1 no. 6 WpHG. Some of the voting
rights are attributed to Federated Equity Management Company of
Pennsylvania by Federated Kaufmann Fund which holds directly 3 per
cent or more of the voting rights in Epigenomics AG.

Federated Investors Inc. is the parent company of F II Holdings Inc.,
which in turn is the parent company of Federated Equity Management
Company of Pennsylvania. Federated Equity Management Company of
Pennsylvania, an investment adviser registered in the United States
under the Investment Company Act of 1940, acts as Investment Adviser
to the Federated Kaufmann Fund and Federated Kaufmann Fund II, both
Massachusetts Business Trusts and Investment Companies, as that term
is defined under the Investment Company Act 1940, as amended.

Date of release: 19 September 2008

Epigenomics AG
The Executive Board

Contact:
Epigenomics AG
Dr. Achim Plum
Sr. Vice President Corporate Development
Tel.: +49 (0)30 24345 368
Fax: +49 (0)30 24345 555
Email: achim.plum@epigenomics.com

--- End of Message ---

Epigenomics AG
Kleine Präsidentenstr.1 Berlin Germany

WKN: A0BVT9;
ISIN: DE000A0BVT96; Index: CDAX, Prime All Share, TECH All Share;
Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime
Standard in Frankfurter Wertpapierbörse,
Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Bayerische Börse München,
Freiverkehr in Börse Stuttgart;
Copyright © Hugin AS 2008. All rights reserved.